Meng Ke Wen

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Tumor Hospital of Xinjiang Medical University(Current)

Xinjiang Medical University

Meng Ke Wen is an author at Tumor Hospital of Xinjiang Medical University specializing in pi3k signaling, mtor inhibition, and synergistic inhibitor effects.

Publications per year

2021–2022

Publications

Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway

Yalikun Muhanmode, Meng Ke Wen, Amina Maitinuri et al. · Human & Experimental Toxicology · 2022 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

RETRACTED: Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway

Yalikun Muhanmode, Meng Ke Wen, Amina Maitinuri et al. · Human & Experimental Toxicology · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2